Friday, June 26, 2015

A Blind Architect leads his Berkeley Students to equitable, barrier-eliminating design solutions

Oh, that we could see as clearly as blind architect Chris Downey. Leading his UC Berkeley seminar students to equitable, barrier-eliminating design solutions or consulting on a 170,000-square-foot blind rehab center at the Veterans Affairs center in Palo Alto or filling the stroke seat on his East Bay Rowing Club team, the 52-year-old Piedmont architect and teacher says he lacks sight, but is not without vision.

Sunglasses should be used from an early age to prevent eye problems in the future

This summer, when your kids pack for summer camp, make sunglasses a top priority in the supply list.

Thursday, June 25, 2015

Results in Ocuvia Diabetic Macular Edema Study show promise

ReVIEW study outcomes so far indicated that Ocuvia, a investigational topical ophthalmic formulation to treat the underlying defects in mitochondria in retinal diseases, shows promise in patients with diabetic macular edema.

Wednesday, June 24, 2015

Stem cells for treatment of diabetic retinopathy - positive results in the lab

University of Virginia School of Medicine researchers have taken a significant step forward in their efforts to use stem cells to block vision loss caused by diabetic retinopathy, a condition that affects millions of people with diabetes. The researchers have evaluated the best potential sources for adult stem cells to be used for that purpose, determining that cells taken from donors who do not suffer diabetes likely will be more effective than cells taken from patients' own bodies.

Patients using Argus II report improvement in visual function and quality of life

The three-year clinical trial results of the retinal implant, popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of the device that restores vision in those blinded by Retinitis Pigmentosa (RP), a rare, degenerative eye disease. The findings show that the Argus II significantly improves visual function and quality of life for people blinded by RP.

Vitamin A may harm patients with Stargardt and possibly macular degeneration

An Oxford University study has found that reducing the tendency of vitamin A to form toxic clumps could slow down retinal degenerative diseases such as Stargardt disease, a condition that leads to blindness in children and young adults, and in age-related macular degeneration.

Tuesday, June 23, 2015

Using computing power to see individual retinal cells

Eye doctors could be using computing power to help them see individual retinal cells. Researchers hope that the detailed pictures gleaned from applying computational adaptive optics can illuminate how changes in the retina correspond to disease severity and track how cells and nerves respond to treatments. Detailed pictures of the cells, blood vessels and nerves at the back of the eye could enable earlier diagnosis and better treatment for degenerative eye and neurological diseases.